Last update 24 Mar 2025

MT-2766

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms-
Target
SARS-CoV-2 S protein
Action
inhibitors
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
COVID-19
Originator Organization
Medicago, Inc.Medicago, Inc.
Active Organization-
Inactive Organization
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.Medicago, Inc.Medicago, Inc.
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MT-2766
NCT05065619
/ TerminatedPhase 1/2
A Phase I/II, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of MT-2766 in Japanese Adults (COVID-19)
100 Clinical Results associated with MT-2766
Login to view more data
100 Translational Medicine associated with MT-2766
Login to view more data
100 Patents (Medical) associated with MT-2766
Login to view more data
100 Deals associated with MT-2766
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
United States
Medicago, Inc.Medicago, Inc.
19 Nov 2020
COVID-19Phase 3
Brazil
Medicago, Inc.Medicago, Inc.
19 Nov 2020
COVID-19Phase 3
Canada
Medicago, Inc.Medicago, Inc.
19 Nov 2020
COVID-19Phase 3
United Kingdom
Medicago, Inc.Medicago, Inc.
19 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05065619 (CTgov)
Phase 1/2
COVID-19
128
(MT-2766 High Dose (3.75 µg))
uwarktanzm = urxkjoeofc zwnkyufjdp (mhxyygebgr, pwoosacdlf - mmkgqgryak)
View more
-
01 May 2023
Placebo
(Placebo)
uwarktanzm = nnnzxtufea zwnkyufjdp (mhxyygebgr, udcnoxlvia - akhghpnvmg)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free